Inferra AI / Company / PHG

Koninklijke Philips

PHG · Health Care

Last earnings Jul 28, 2026

Key results

Nominal revenuequarter

3 %

* Quarterly Report 2025 - Q2 5 Performance per segment Diagnosis Treatment Key data in millions of EUR unless otherwise stated * Q2 2024 Q2 2025 Sales 2,174 2,084 Nominal sales growth 3 % (4 %) Comparable sales growth 4 % (1 %) Income from operations 211 226 as a % of sales 9.7 % 10.8 % EBITA 234 244 as a % of sales 10.8 % 11.7 % Adjusted EBITA 265 281 as a % of sales 12.2 % 13.5 % Adjusted EBITDA 314 325 as a % of sales 14.4 % 15.6 % 1 Non-IFRS financial measure.

SEC original ↗Koninklijke Philips — Earnings release (6-K report)6-KJul 29, 2025

Comparable revenuequarter

4 %

SEC original ↗Koninklijke Philips — Earnings release (6-K report)6-KJul 29, 2025

Revenuequarter

9.7 %

SEC original ↗Koninklijke Philips — Earnings release (6-K report)6-KJul 29, 2025

Semi-annual report 2025 8 Performance per segment Diagnosis Treatment Key data in millions of EUR unless otherwise stated January to June 2024 2025 Sales 4,200 4,048 Sales growth Nominal sales growth 2 % (4 %) Comparable sales growth 4 % (3 %) Income from operations 357 379 as a % of sales 8.5 % 9.4 % EBITA 402 417 as a % of sales 9.6 % 10.3 % Adjusted EBITA 452 468 as a % of sales 10.8 % 11.6 % Adjusted EBITDA 549 560 as a % of sales 13.1 % 13.8 % 1 Non-IFRS financial measure.

SEC original ↗Koninklijke Philips — Earnings release (6-K report)6-KJul 29, 2025

AI analysis

Q2 2025 · reported Jul 29, 2025

Based on: Earnings release — transcript not held

Headline figures

Metric	Q2 2025	Prior qtr	Year ago
Nominal revenue	3 %	—	—
Comparable revenue	4 %	—	—
Revenue	9.7 %	—	—

6-K · Jul 29, 2025

Guidance · company-stated

Direction: Raised

Revenue

“van Ginneken (Chief Legal Officer) Quarterly report Q2 2025 Philips builds strong order intake momentum and drives margin expansion in Q2 Amsterdam, July 29, 2025 Q2 2025 Group Highlights Comparable order intake growth 6% G roup sales EUR 4.3 billion, reflecting 1% increase in comparable sales Income from operations EUR 400 million Adjusted EBITA margin increased 130 bps to 12.4% of sales Free cash flow increased to EUR 230 million Philips increases full year 2025 outlook for Adjusted EBITA margin and free cash flow reiterates comparable sales growth outlook Roy Jakobs, CEO of Royal Philips We are focused on driving profitable growth and delivering better care for more people.”

Revenue

“We increase our full year outlook for margin and free cash flow, including currently announced tariff levels, and we reiterate our comparable sales growth outlook as we continue to build order and sales momentum.”

Revenue

“Outlook Philips updates its outlook, including currently announced tariff impact, which has evolved and continues to be dynamic Comparable sales growth range reiterated at 1%-3% with sequential improvement as the year progresses.”

Margin

“Adjusted EBITA margin range increased to 11.3%-11.8%, a 50 bps increase versus our previous outlook.”

Classified from the release's primary full-year outlook statement.

Next earningsNo verified date on fileNo date is estimated or imported

Capital allocation

Capital Allocation Philips completed its dividend distribution for 2024 in the second quarter of 2025.

As approved by the Annual General Meeting of Shareholders on May 8, 2025, a dividend of EUR 0.85 per common share was paid in cash or shares at the election of the shareholder, with 41.4% paid in cash.

General educational research only — not investment advice.Every figure is as stated in the held documents; values marked “computed from stated figures” are arithmetic on those stated figures. Guidance shown is the company’s own stated guidance. No price targets, no recommendations, no consensus estimates.

Event summary

Prinses Irenestraat 59 1077 WV Amsterdam The Netherlands This report comprises a copy of the following report Philips' Second Quarter Results 2025 , dated July 29, 2025

Based on: Earnings release — transcript not held

Guidance & outlook

Direction: Raised

Revenue: “van Ginneken (Chief Legal Officer) Quarterly report Q2 2025 Philips builds strong order intake momentum and drives margin expansion in Q2 Amsterdam, July 29, 2025 Q2 2025 Group Highlights Comparable order intake growth 6% G roup sales EUR 4.3 billion, reflecting 1% increase in comparable sales Income from operations EUR 400 million Adjusted EBITA margin increased 130 bps to 12.4% of sales Free cash flow increased to EUR 230 million Philips increases full year 2025 outlook for Adjusted EBITA margin and free cash flow reiterates comparable sales growth outlook Roy Jakobs, CEO of Royal Philips We are focused on driving profitable growth and delivering better care for more people.”

Revenue: “We increase our full year outlook for margin and free cash flow, including currently announced tariff levels, and we reiterate our comparable sales growth outlook as we continue to build order and sales momentum.”

Revenue: “Outlook Philips updates its outlook, including currently announced tariff impact, which has evolved and continues to be dynamic Comparable sales growth range reiterated at 1%-3% with sequential improvement as the year progresses.”

Margin: “Adjusted EBITA margin range increased to 11.3%-11.8%, a 50 bps increase versus our previous outlook.”

Revenue — Raised (“increase”)
“van Ginneken (Chief Legal Officer) Quarterly report Q2 2025 Philips builds strong order intake momentum and drives margin expansion in Q2 Amsterdam, July 29, 2025 Q2 2025 Group Highlights Comparable order intake growth 6% G roup sales EUR 4.3 billion, reflecting 1% increase in comparable sales Income from operations EUR 400 million Adjusted EBITA margin increased 130 bps to 12.4% of sales Free cash flow increased to EUR 230 million Philips increases full year 2025 outlook for Adjusted EBITA margin and free cash flow reiterates comparable sales growth outlook Roy Jakobs, CEO of Royal Philips We are focused on driving profitable growth and delivering better care for more people.”

Revenue — Raised (“increase”)
“We increase our full year outlook for margin and free cash flow, including currently announced tariff levels, and we reiterate our comparable sales growth outlook as we continue to build order and sales momentum.”

Revenue — Reiterated (“reiterated”)
“Outlook Philips updates its outlook, including currently announced tariff impact, which has evolved and continues to be dynamic Comparable sales growth range reiterated at 1%-3% with sequential improvement as the year progresses.”

Margin — Raised (“increased”)
“Adjusted EBITA margin range increased to 11.3%-11.8%, a 50 bps increase versus our previous outlook.”

Classified from the release's primary full-year outlook statement.

Capital allocation

Capital Allocation Philips completed its dividend distribution for 2024 in the second quarter of 2025.

SEC original ↗Koninklijke Philips — Earnings release (6-K report)6-KJul 29, 2025

Per share calculations have been adjusted retrospectively for all periods presented to reflect the issuance of shares in 2025 with respect to the share dividend for 2024.

SEC original ↗Koninklijke Philips — Earnings release (6-K report)6-KJul 29, 2025

Cash and cash equivalents balance in millions of EUR Q2 2024 Q2 2025 Beginning cash balance 1,402 1,193 Free cash flow (64) 230 Net cash flows from operating activities 89 387 Net capital expenditures (153) (156) Other cash flows from investing activities (10) (69) Treasury shares transactions (113) 1 Changes in debt 587 840 Dividend paid to shareholders (1) (295) Other cash flow items 5 (79) Ending cash balance 1,807 1,822 1 Non-IFRS financial measure.

SEC original ↗Koninklijke Philips — Earnings release (6-K report)6-KJul 29, 2025

Changes in debt in Q2 2025 mainly includes the new EUR 1 billion bonds issued in May 2025, partly offset by debt repayments.

SEC original ↗Koninklijke Philips — Earnings release (6-K report)6-KJul 29, 2025

Dividend paid to shareholders in 2025 reflects the cash portion of the dividend and related withholding tax, whereas the dividend in 2024 was fully settled in shares.

SEC original ↗Koninklijke Philips — Earnings release (6-K report)6-KJul 29, 2025

Strategy & priorities

van Ginneken (Chief Legal Officer) Quarterly report Q2 2025 Philips builds strong order intake momentum and drives margin expansion in Q2 Amsterdam, July 29, 2025 Q2 2025 Group Highlights Comparable order intake growth 6% G roup sales EUR 4.3 billion, reflecting 1% increase in comparable sales Income from operations EUR 400 million Adjusted EBITA margin increased 130 bps to 12.4% of sales Free cash flow increased to EUR 230 million Philips increases full year 2025 outlook for Adjusted EBITA margin and free cash flow reiterates comparable sales growth outlook Roy Jakobs, CEO of Royal Philips We are focused on driving profitable growth and delivering better care for more people.

SEC original ↗Koninklijke Philips — Earnings release (6-K report)6-KJul 29, 2025

Sales improved, including accelerated Personal Health sales growth, and we delivered margin expansion through innovation and productivity.

SEC original ↗Koninklijke Philips — Earnings release (6-K report)6-KJul 29, 2025

Our focus on innovation and strong execution is driving impact as we continue to put patient safety and quality as our number one priority.

SEC original ↗Koninklijke Philips — Earnings release (6-K report)6-KJul 29, 2025

Productivity Disciplined cost management and robust productivity initiatives delivered savings of EUR 197 million in the quarter.

SEC original ↗Koninklijke Philips — Earnings release (6-K report)6-KJul 29, 2025

Examples of forward-looking statements include statements made about our strategy, estimates of sales growth, future Adjusted EBITA*, future restructuring and acquisition-related charges and other costs, future developments in Philips organic business and the completion of acquisitions and divestments.

SEC original ↗Koninklijke Philips — Earnings release (6-K report)6-KJul 29, 2025

Risks & headwinds

We increase our full year outlook for margin and free cash flow, including currently announced tariff levels, and we reiterate our comparable sales growth outlook as we continue to build order and sales momentum.

SEC original ↗Koninklijke Philips — Earnings release (6-K report)6-KJul 29, 2025

Adjusted EBITA margin increased by 130 basis points to 12.4%, driven by higher gross margin from innovation, product mix and productivity measures that more than offset the initial impact of increased tariffs and currency headwinds.

SEC original ↗Koninklijke Philips — Earnings release (6-K report)6-KJul 29, 2025

Outlook Philips updates its outlook, including currently announced tariff impact, which has evolved and continues to be dynamic Comparable sales growth range reiterated at 1%-3% with sequential improvement as the year progresses.

SEC original ↗Koninklijke Philips — Earnings release (6-K report)6-KJul 29, 2025

This includes an estimated tariff impact of EUR 150-200 million after substantial mitigations, compared to EUR 250-300 million previously Adjusted EBITA margin in Q3 expected to be lower than in 2024 primarily due to tariff impact phasing.

SEC original ↗Koninklijke Philips — Earnings release (6-K report)6-KJul 29, 2025

Income from operations increased by EUR 562 million, mainly driven by the comparative impact of EUR 982 million for the Respironics litigation provision, which was partly offset by EUR 538 million insurance income related to the Respironics product liability claims recorded in the first half of 2024, as well as higher gross margin, and lower charges in restructuring, acquisition-related and other items.

SEC original ↗Koninklijke Philips — Earnings release (6-K report)6-KJul 29, 2025

Income from operations increased by EUR 492 million, mainly driven by the comparative impact of the EUR 982 million Respironics litigation provision, which was partly offset by EUR 538 million insurance income related to Respironics product liability claims recorded in the first half of 2024.

SEC original ↗Koninklijke Philips — Earnings release (6-K report)6-KJul 29, 2025

Documents